Tag Archives: Nanaimo

SAQ

Tilray® Signs Letter of Intent with Société des alcools du Québec (SAQ) to Supply Province with Cannabis

Tilray® Signs Letter of Intent with Société des alcools du Québec (SAQ) to Supply Province with Cannabis

NANAIMO AND MONTREAL, Feb. 14, 2018 /Weed Wire/ – Tilray, a global pioneer in cannabis cultivation, processing and distribution, announced today that it has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year.

SAQ

Tilray Receives Support For Medical Cannabis Innovation

NANAIMO, British Columbia, Nov. 30, 2017 /Weed Wire/ — We’re excited to announce that Tilray received research funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support product development and other research projects.

SAQ

Tilray Exports Medical Cannabis Genetics to the European Union

NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.

SAQ

Tilray Exports Medical Cannabis Products to New Zealand for Nationwide Distribution

NANAIMO, British Columbia, Sept. 28, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide.

SAQ

Tilray Announces Second Facility Enabling 5x Increase in Production Capacity

NANAIMO, British Columbia, Aug. 17, 2017 /Weed Wire/ — Tilray Canada Ltd., a Good Manufacturing Practice (GMP)-certified global leader in medical cannabis research and production, announced today that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario.

SAQ

Tilray Announces Support for Clinical Trial Examining Cannabis and Chronic Lung Disease

NANAIMO, British Columbia, June 15, 2017 / Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD).

SAQ

Tilray Unveils New Product Categorization System in Canada

NANAIMO, British Columbia, May 15, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today unveiled a new product categorization system that simplifies the process of choosing medical cannabis products for patients in Canada.

SAQ

Tilray Announces Medical Cannabis Export to Cyprus

NANAIMO, British Columbia, May 4, 2017 /Weed Wire/ – Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus.

SAQ

Tilray Announces Medical Cannabis Export to New Zealand

NANAIMO, British Columbia, Feb. 14, 2017 /Weed Wire/ — Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary approvals in Canada and New Zealand to export medical cannabis to New Zealand.

SAQ

Tilray Announces Medical Cannabis Export to Chile

NANAIMO, British Columbia, Feb. 1, 2017 /Weed Wire/ —Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary regulatory approvals in Canada and Chile to export medical cannabis for distribution to Chilean patients.


Top